• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·3593.T
Share

Hogy Medical Co.,Ltd. Stocks

¥ 6660Last Updated 19.05.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

¥ 895.99M

¥ 6660
Key Takeaways

Risk factor

Limited trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Hogy Medical Co.,Ltd., along with its associated companies, is dedicated to providing medical provisions to healthcare institutions throughout Japan. Their product portfolio encompasses all-inclusive surgical kit solutions designed for pre-operative, intra-operative, and post-operative stages. They also manufacture a variety of non-woven items, such as surgical gowns, personal protective equipment, patient attire, drapes, pre-packaged goods, covers for instrument tables, and wraps. A unique offering is Tigalyer, a specialized multi-layer fabric. For effective sterilization, the company produces hybrid Mekkin bags, including an ID-layered variant, along with autoclave forceps stand caps. Furthermore, Hogy Medical offers Mekkin cards and ethylene oxide gas cards, both crucial for verifying the sterilization process in autoclaves and using ethylene oxide gas, respectively, complemented by indicator tapes for autoclave sterilization. On the technology front, they provide an ME equipment operation management system and an automated system leveraging radio frequency identification (RFID) to manage controlled medications and hazardous substances. Another innovative product is Securea, a polyurethane sponge specifically engineered for endoscopic surgical procedures. Founded in Tokyo, Japan, in 1955, the company operated as Hogy Co., Ltd. until 1987, when it officially changed its name to Hogy Medical Co.,Ltd.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of 3593.T is 3810 and suggests 43% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.09.2026 00:58

Data from some Revolut customers was leaked

12.09.2026 16:01

Small caps last week: Chewy's earnings miss, Signet's best day ever, AE rethinks ads

12.09.2026 13:01

The iPhone Reboot, the AGI Era, and Silicon Valley's Right Turn

12.09.2026 05:06

Spam from OpenAI's AI agents disrupted the developer service for four days

12.09.2026 03:52

Citrini, the founder who spooked the market with his prediction of AI threats, has sold the company. What's next?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026